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Abstract 
SWATH-mass spectrometry (MS) enables accurate and reproducible proteomic profiling in 
multiple model organisms including the mouse. Here we present a comprehensive mouse 
reference spectral library (MouseRefSWATH) that permits quantification of up to 10,597 
proteins (62.2% of the mouse proteome) by SWATH-MS. We exploit MouseRefSWATH to 
develop an analytical pipeline for species-specific deconvolution of proteomic alterations in 
human tumour xenografts (XenoSWATH). This method overcomes the challenge of high 
sequence similarity between mouse and human proteins, facilitating the study of host 
microenvironment-tumour interactions from ‘bulk tumour’ measurements. We apply the 
XenoSWATH pipeline to characterise an intraductal xenograft model of breast ductal 
carcinoma in-situ and uncover complex regulation consistent with stromal reprogramming, 
where the modulation of cell migration pathways is not restricted to tumour cells but also 
operate in the mouse stroma upon progression to invasive disease. MouseRefSWATH and 
XenoSWATH opens new opportunities for in-depth and reproducible proteomic assessment 
to address wide-ranging biological questions involving this important model organism. 
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Introduction 
Mass spectrometry (MS) has become an essential tool for contemporary proteomic research 
in life sciences. Conventional data-dependent acquisition (DDA) mode, where a fixed number 
of the most abundant precursor ions in survey scans are automatically selected for 
fragmentation, enables the identification of thousands of proteins in a single MS experiment. 
However, the stochastic nature of peptide precursor ion selection in DDA leads to low 
reproducibility in peptide identification between experimental runs ranging from 35-60% (Tabb 
et al., 2010, Krasny et al., 2018, Bruderer et al., 2015, Barkovits et al., 2020). Sequential 
window acquisition of all theoretical mass spectra (SWATH-MS) or data-independent 
acquisition mass spectrometry (DIA-MS) is a next-generation label-free quantification method 
that enables highly reproducible peptide identification (ranging from 80-98%) and more 
accurate quantification in large-scale proteomic analyses across multiple experiments (Gillet 
et al., 2012, Muntel et al., 2019, Collins et al., 2017, Bruderer et al., 2015, Barkovits et al., 
2020). In contrast to DDA, the SWATH methodology captures all peptide precursor ions in a 
sample under investigation and fragments these ions in a series of wide and adjacent isolation 
windows that cover the entire mass to charge ratio (m/z) range measured (Gillet et al., 2012). 
This approach leads to the generation of a final digital proteome map comprising 
fragmentation spectra of all detected peptides in each sample for subsequent in silico analysis 
(Guo et al., 2015). The ability to capture all peptide precursor ions dramatically improves 
reproducibility in protein identification across multiple samples. These quantitative digital 
proteome maps have been shown to have wide applications in medical research such as the 
discovery of potential biomarkers and therapeutic targets (Cecchettini et al., 2019, Gao et al., 
2017, Miyauchi et al., 2018, Hou et al., 2016, Xu et al., 2018) as well as tumour proteotyping 
for cancer stratification and classification (Bouchal et al., 2019, Zhu et al.).  
 
Key to the success of SWATH-MS is the use of retention-time calibrated spectral libraries to 
identify and quantify peptides from the complex fragment ion mass spectra encoded within 
digital proteome maps (Bruderer et al., 2016). While most published SWATH-MS studies have 
utilised study-specific experimentally derived spectral libraries, this approach is time 
consuming and is prone to wide variation between laboratories due to the lack of 
standardisation in DDA data acquisition and library generation. Such variation results in study-
specific bias and poor inter-laboratory reproducibility. The recent development of the 
algorithms that control for false discovery rate (FDR) in SWATH-MS datasets has opened up 
the possibility of building large reference spectral libraries that can be readily shared by the 
community, increasing data reproducibility across laboratories and accelerating SWATH-MS 
experiments without the need to generate study-specific spectral libraries (Reiter et al., 2009, 
Rosenberger et al., 2014).  
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 Several such large reference spectral libraries have been built and deposited into repositories 
such as SWATHAtlas (www.SWATHatlas.org) including libraries for human (Rosenberger et 
al., 2014), fruit fly (Fabre et al., 2017), zebrafish (Blattmann et al., 2019) and yeast (Picotti et 
al., 2013). There is however currently no publically available comprehensive mouse reference 
spectral library. The mouse as a model organism has and continues to be extensively used in 
developmental biology and medical research due to the complex genetics and physiological 
systems that mammals share. The array of innovative genetic strategies available for 
engineering mice has revolutionised our understanding of multiple human diseases including 
cancer, diabetes, autoimmune disease and heart disease amongst others. Furthermore, 
immunocompromised mouse models have been used for more than a decade as hosts for 
human tumour (both cell line and patient-derived) xenografts which have served as an 
essential tool to investigate the factors that drive carcinogenesis as well as to evaluate cancer 
therapeutics (Richmond and Su, 2008). Developing a comprehensive mouse reference 
spectral library will facilitate the application of SWATH-MS to address key research questions 
involving this widely used model organism. A number of study-specific mouse spectral libraries 
have previously been reported (Caron et al., 2015, Williams et al., 2018, von Ziegler et al., 
2018, Malmstrom et al., 2016), for instance a spectral library that is comprised of the mouse 
immunopeptidome containing 1573 peptides presented by MHC class I molecules (Caron et 
al., 2015) and a spectral library reported by Williams et al. which is comprised of 5152 proteins 
(30% of mouse proteome) generated from five organs (Williams et al., 2018). Notably, in the 
aforementioned human tumour xenograft models, a small number of DDA-MS studies have 
described the deconvolution of host (mouse) versus tumour (human) proteomic alterations 
from ‘bulk tumour’ proteomes (Rajcevic et al., 2009, Wang et al., 2017, Wildburger et al., 
2015); but these studies lack the reproducibility afforded by SWATH-MS which has limited our 
ability to robustly study the role of the tumour microenvironment in driving tumour initiation and 
progression. 
 
In this study, we present a comprehensive mouse reference spectral library 
(MouseRefSWATH) generated from 15 distinct mouse organs and cellular samples. 
MouseRefSWATH was built from 254 individual MS experiments and is composed of 
transitions for 167,138 proteotypic peptides from 10,597 proteins representing 62.2% of 
manually validated mouse protein-encoding genes (Swissprot database). The performance of 
MouseRefSWATH was evaluated in two publicly available SWATH-MS datasets which 
showed both qualitative and quantitative reproducibility when compared to published study-
specific spectral libraries. We further report the development of a novel application of 
MouseRefSWATH for SWATH-MS-based mapping of species-specific temporal proteomic 
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alterations in an orthotopic tumour xenograft model of breast ductal carcinoma in situ (DCIS). 
Utilising this approach, we reveal for the first time, simultaneous temporal regulation of cell 
migration pathways in both the host mouse mammary gland and human tumour cells during 
the course of DCIS to invasive breast cancer (IBC) progression. This XenoSWATH pipeline 
for species-specific deconvolution of ‘bulk tumour’ proteomics data provides a useful tool with 
broad applications for the analysis of host microenvironment-tumour interactions in xenograft 
models without the need for prior separation of host and tumour cell populations. The MS raw 
data and MouseRefSWATH spectral library for this study is available via ProteomeXchange 
with identifier PXD017209. 
 
Results 
Proteomic analysis of murine tissue and cells. 
To maximize coverage of the mouse proteome in the reference spectral library, we performed 
DDA proteomic analysis of a comprehensive range of 7 murine organs comprising heart, brain, 
lung, liver, kidney, lymph node and mammary gland (Figure 1 and Table 1). In addition, we 
undertook proteomic profiling from primary CD8+ T-lymphocytes (non-stimulated and 
activated) as well as immortalised murine cell lines including normal (NF1) and cancer-
associated (CAF1) fibroblasts (Calvo et al., 2013) and commercially available cell lines NIH-
3T3, C2C12, 4T1 and Ba/F3 of diverse tissue origin (Table 1). As outlined in the workflow 
shown in Figure 1, extracted proteins from each sample type were digested by trypsin and the 
resulting peptide mixture was subjected to offline fractionation in the first dimension either by 
strong cation exchange (SCX) chromatography or reverse phase chromatography in high pH 
(HpH-RP) (Table 2). To calibrate the chromatographic retention time for individual DDA runs, 
prior to liquid chromatography tandem mass spectrometry (LC-MS/MS) analysis each fraction 
was spiked with the iRT calibration standard that contains mixture of 11 synthetic peptides 
(Escher et al., 2012, Bruderer et al., 2016). Peptides from each fraction were subsequently 
analysed by LC-MS/MS in DDA mode and the acquired data were processed by SpectroMine 
(Keller et al., 2005, Deutsch et al., 2010). An average of between 3200-6600 proteins were 
identified across the different samples as shown in Table 2. 
 
Building the MouseRefSWATH spectral library 
We built the mouse reference spectral library (MouseRefSWATH) from the datasets listed in 
Table 2 by employing the SpectroMine software (Figure 1). Only unique protein-specific 
(proteotypic) peptides were used to generate the library which comprise 10,597 proteins 
(Figure 2A), representing 62.2% coverage of manually annotated mouse protein-coding genes 
(Swissprot, 26/10/2018). Comparative analysis demonstrates a superior proteome coverage 
versus published spectral libraries of other higher eukaryotic organisms (human – 51% 
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(Rosenberger et al., 2014) and zebrafish – 40.4% (Blattmann et al., 2019)) (Figure 2B). Figure 
2C shows the distribution of unique peptides per protein group with 90.6% of proteins 
represented by >1 unique peptide in the spectral library and 46.7% of proteins being 
represented by >10 unique peptides. The contribution plot (Figure 2D) shows that 1949 
proteins (18.4%) in the MouseRefSWATH library were detected in all analysed sample types 
used in the generation of the library. The brain contributed the highest number of proteins 
(551, 5.2%) to the MouseRefSWATH library, followed by T cells (165, 1.6%) and lung (127, 
1.2%). 
 
Evaluating the performance of the MouseRefSWATH spectral library 
To demonstrate the utility of the MouseRefSWATH library and benchmark its performance 
against study-specific libraries generated as part of published SWATH-MS studies, we applied 
the reference spectral library to 2 publicly available SWATH-MS datasets focused on 
mitochondrial (Williams et al., 2018) and hippocampal (von Ziegler et al., 2018) proteins 
(Figure 1). These datasets were generated by quadrupole time-of-flight instruments and 
comprise of MS runs that have included the iRT calibration standard. It should be noted that 
the use of the MouseRefSWATH spectral library for retrospective and prospective analysis 
requires spiking in of the iRT calibration standard so that the appropriate retention time 
calibration can be performed.. Each dataset was analysed using either the original study-
specific library generated by the authors or the MouseRefSWATH library.  
 
In a recent mitoproteome study undertaken by Williams et al. (Williams et al., 2018), a study-
specific library based on DDA analysis of both total tissue lysates and mitochondria-enriched 
samples was utilised. We sought to assess the extent to which the MouseRefSWATH library 
was able to both qualitatively and quantitatively recapitulate the data generated by the study-
specific library in the published study. The SWATH-MS data of mitochondrial proteins was 
downloaded from ProteomeXchange (PXD005044) and analysed using both libraries (Figure 
2E & F). The Williams et al. experimental dataset was generated from mitochondria enriched 
from 5 distinct murine tissues (brown adipose tissue (BAT), heart, liver, quadriceps, brain,) 
from 5-8 animals. Qualitatively, the MouseRefSWATH library identified 91.1% (640 proteins) 
of the mitoproteome (Figure 2E) found using the study-specific library with an additional 26 
proteins identified specifically by the MouseRefSWATH library. An assessment of the 
quantification of the 640 overlapping proteins showed a good correlation between both 
libraries with Pearson’s correlation coefficient r values ranging between 0.92 – 0.95 (Figure 
2F).  
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We undertook a similar comparative analysis on the study by von Ziegler et al. (von Ziegler et 
al., 2018) where the basal mouse hippocampal proteome was analysed utilising a study-
specific spectral library built from DDA data generated from the mouse hippocampus. For this 
analysis, the SWATH-MS experimental data of hippocampal area CA1 and CA3 from 6 
different animals were analysed (Figure 2G & H). The MouseRefSWATH library identified 
80.2% (943 proteins) of hippocampus proteome found using the study-specific spectral library 
(Figure 2G). The MouseRefSWATH library further identified 211 more proteins compared to 
the hippocampus-specific spectral library. Good correlation in protein quantification between 
the MouseRefSWATH and study-specific library for the overlapping 943 proteins was 
observed with Pearson’s correlation coefficient r values ranging between 0.78-0.81 across the 
6 mice in the experiment (Figure 2H). Taken together, our analysis demonstrates that applying 
the MouseRefSWATH to SWATH-MS datasets is routinely able to identify >80% of proteins 
identified using study-specific libraries with comparable quantification, highlighting its broad 
utility as a general reference library applicable for use in multiple mouse SWATH-MS datasets 
without the need to generate study-specific libraries.  
 
Developing the XenoSWATH analysis pipeline for deconvolution of mouse and human 
proteins in tumour xenograft SWATH-MS data 
Mouse xenograft studies are one of the cornerstones of modern cancer research where 
human tumour cells are typically grafted into a mouse host either subcutaneously or 
orthotopically as a means to evaluate oncogene and tumour suppressor gene function or 
investigate the therapeutic effects of drugs (Rosenbluh et al., 2012, Rosato et al., 2018). In 
these models, there are complex interactions between the human tumour cells and the host 
microenvironment which play important roles in driving cancer progression and therapy 
response (Jansen et al., 2005, Hu et al., 2008, Lyons et al., 2011). To study these interactions, 
previous proteomic studies have attempted to tackle this challenge by separating human 
tumour and murine host cells utilising immunoaffinity cell enrichment strategies prior to MS 
analysis (Kalita-de Croft et al., 2019). However, such methods are labour intensive, introduce 
sample preparation biases and disrupt the in situ architecture and cellular interactions 
important for driving tumour biology. There have also been a small number of DDA-MS studies 
that have used either label-free methods or isobaric labelling to identify species-specific 
signalling in xenograft models of glioma and breast cancer (Wildburger et al., 2015, Rajcevic 
et al., 2009, Wang et al., 2017), however these methods suffer from low reproducibility in 
peptide identification between individual experimental runs (Bruderer et al., 2015, Barkovits et 
al., 2020).  
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To address these challenges, we developed a novel pipeline (XenoSWATH) to deconvolute 
species-specific proteomic profiles from SWATH-MS data obtained in mouse xenograft 
experiments. In this XenoSWATH workflow (Figure 3), both the MouseRefSWATH library as 
well as a previously published pan-Human reference library (Rosenberger et al., 2014) were 
used in the Spectronaut software (Reiter et al., 2009). In the first step of data processing, 
peptides were identified by searching the acquired SWATH-MS data against either the 
MouseRefSWATH or pan-Human library. Both libraries contain proteotypic peptides which can 
distinguish individual proteins, however given that humans and mice share ~70% of protein 
coding sequences (Waterston et al., 2002), not all of these proteotypic peptides are also 
species-discriminating. Therefore to selectively quantify human and mouse proteins from ‘bulk 
tumour xenograft’ proteomic datasets, we focused on peptides that are both protein- and 
species-discriminating (see Figure 3 for example). To achieve this, rather than using individual 
FASTA files comprising in silico digested peptides for either human or mouse proteins, we 
instead manually combined both files into a single FASTA file for peptide quantification. This 
modification to the data processing pipeline enables Spectronaut to compare sequences of 
the identified peptides from either the mouse or human reference spectral library with the 
sequences of the in silico digested peptides within the combined FASTA file; and filter out any 
peptides that are shared between human and mouse. This leads to the retention of only 
peptides that are both proteotypic and species-discriminating for peptide quantification. The 
resultant output from this XenoSWATH pipeline is two datasets -one comprising entirely of 
murine proteins and the other of human proteins.  
 
SWATH-MS analysis and deconvolution of tumour (human) and host mammary gland (mouse) 
proteomic alterations in a xenograft model of DCIS progression. 
We applied the XenoSWATH deconvolution pipeline to quantify the species-specific proteomic 
alterations associated with DCIS progression to IBC in an orthotopic mouse intraductal breast 
DCIS (MIND) xenograft model. The MIND model is based on the injection of human breast 
DCIS cells such as the MCF10DCIS.com cell line into the mouse mammary duct (Figure 4A) 
(Behbod et al., 2009, Sflomos et al., 2016, Miller et al., 2000). Compared to the other breast 
cancer xenograft models such as subcutaneous and mammary fat pad injection, the MIND 
model has been shown to better recapitulate the mammary gland microenvironment (Sflomos 
et al., 2016), a key regulator of breast cancer progression (Hu et al., 2008, Nelson et al., 2018), 
and is therefore a more clinically relevant model for this disease. In our experiments, 
MCF10DCIS.com-Luc cells were injected intraductally into the mammary glands of mice 
where they form tumours that faithfully model the process of DCIS progression over the course 
of 10 weeks (Figure 4B-D) (Behbod et al., 2009). Tumours at 4 weeks post injection 
(referenced as 4w, number of biological replicates n=7) mimic non-invasive DCIS lesions, 
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while after 6 weeks of growth (6w, n=7), tumours start microinvading into the surrounding 
tissue and finally progress to full IBC at 10 weeks (10w, n=8) post injection (Figure 4D). There 
is a significant increase in size of the 10w lesions compared to the 4w (p=0.0012) and 6w 
(p=0.0059) lesions but no significant difference in tumour size between 4w and 6w lesions 
(p=0.317) (Figure 4B-C) when most lesions at 6w remain within the duct and only a few cells 
are microinvading out of the ducts. 
 
Whole mammary glands with tumour (n=4) were collected after 4, 6 and 10 weeks post 
injection and subjected to SWATH-MS analysis (Figure 4A). When processed through the 
XenoSWATH pipeline (Figure 3), we successfully quantified 2,086 murine and 1,177 human 
proteins in all samples across the three time-points (Table S1 and S2). Our analysis showed 
no significant differences in protein expression levels in both human and murine datasets 
between the 4w and 6w specimens, indicating that the non-invasive DCIS lesions (4w) and 
tumours with microinvasion (6w) harbour similar proteomic profiles at this level of resolution. 
Comparing the 4w and 6w data with the 10w lesions led to the identification of 327 murine and 
247 human proteins that showed significant changes in protein expression (Table S3 and S4).  
 
Gene set enrichment analysis (GSEA) was performed to identify functional ontologies that 
were enriched in the murine and human proteomic datasets upon DCIS progression to IBC 
(Figure 4E and Table S5). This analysis showed a number of ontology networks that were 
almost exclusively enriched in either in the human tumour cells (cell death & apoptosis, protein 
localisation to membrane and epithelial cell development) or the mouse stroma (cell adhesion, 
actin filament organisation and innate immune response) (Figure 4F). Notably, we identified 
16 overlapping ontologies that were upregulated in both species, the majority of which were 
associated with increased cell migration (Figure 4E-F). An assessment of the upregulated 
proteins (Log2 fold change >0.58) in a subset of these overlapping ontologies revealed a 
complex regulation of protein networks in both the human and mouse compartments. For 
instance, within the networks regulating cell motility and locomotion (Figure 4F), specific 
proteins were upregulated in the tumour cells only [e.g macrophage inhibitory factor (MIF) and 
peptidylprolyl isomerase A (PP1A)], host cells only [e.g. S100a8 and S100a9]; or in both 
compartments [e.g. Galectin-3 (LGALS3), Fibronectin (FN1), Ezrin (EZR), CD44 antigen 
(CD44)]. Employing the deconvolution pipeline, our analyses demonstrates for the first time 
that the temporal upregulation of cell migration pathways consistent with DCIS to IBC 
progression is not restricted only to the tumour cells but is found to also operate in the host 
tumour microenvironment. This proof-of-principle experiment demonstrates the utility of our 
XenoSWATH deconvolution pipeline for the comprehensive mapping of temporal alterations 
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in the tumour versus host proteome in tumour xenograft models and its ability to capture 
relevant tumour biology for subsequent investigation.  
 
Discussion 
In this study, we have built the first comprehensive mouse reference spectral library 
(MouseRefSWATH) for SWATH-MS applications. The MouseRefSWATH library is generated 
from proteomic datasets acquired across wide range of murine tissue samples, primary cells 
and cell lines which facilitates versatile use in proteomic profiling of various sample types. We 
demonstrate its utility in two publicly available SWATH-MS datasets where the use of 
MouseRefSWATH identified and accurately quantified >80% of the proteins compared to 
study-specific libraries with a Pearson’s correlation coefficient for protein quantification of at 
least 0.78. In both datasets, the MouseRefSWATH library further identified new proteins which 
would have otherwise not been possible with study-specific libraries. Moving forward, 
researchers who seek to undertake a murine SWATH-MS experiment need only to download 
and use the publicly available MouseRefSWATH library, thereby dispensing with the 
requirement to generate study-specific libraries, ultimately saving time and costs. 
 
We have also extended the use of the MouseRefSWATH library and developed a novel 
analysis pipeline called XenoSWATH that enables deconvolution of murine and human 
proteins from ‘bulk tumour’ xenograft proteomic measurements through the identification of 
species-discriminating proteotypic peptides. The lack of tools to perform a deep analysis of 
tumour (human) and host (mouse) molecular alterations in situ have limited our ability to study 
the role of the tumour microenvironment in driving tumour progression. In silico approaches 
have been developed to deconvolute mouse and human reads in next generation DNA and 
RNA sequencing data derived from tumour xenografts but such tools are limited in proteomic 
data analysis (Kluin et al., 2018). Prior studies using DDA-MS in human glioma and breast 
cancer xenografts have identified species-specific proteins in the range of 1000-2000 mouse 
or human proteins (Rajcevic et al., 2009, Wang et al., 2017, Wildburger et al., 2015). However, 
due to the stochastic nature of this MS method, there is poor reproducibility in protein 
identification across independent experiments (~50%) in some of these previous studies 
(Wang et al., 2017). The only published application of SWATH-MS in a xenograft model thus 
far has focused on measuring the murine stromal component by pre-enrichment of mouse 
cells with immunoaffinity chromatography while completely omitting the human tumour cells 
(Kalita-de Croft et al., 2019). XenoSWATH confers the ability to distinguish and reproducibly 
map proteomic alterations in both the human and mouse compartments with comparable 
protein identification numbers as DDA-MS and provides a new approach to investigating 
tumour cell-microenvironmental interactions in cancer initiation, progression and therapy 
D
is
ea
se
 M
o
de
ls
 &
 M
ec
ha
ni
sm
s 
• 
D
M
M
 •
 A
cc
ep
te
d 
m
an
us
cr
ip
t
response. With the recent development of human tumour xenograft models in 
immunodeficient zebrafish (Yan et al., 2019), we anticipate that XenoSWATH can be readily 
extended to the study of host and tumour cell responses in these models by similarly utilising 
the zebrafish reference spectral library available in SWATHAtlas (Blattmann et al., 2019).  
 
As proof-of-principle, we undertook a quantitative proteomic analysis in the MIND model and 
provide the first characterisation of host stroma and tumour cell proteomic alterations that 
occur during DCIS to IBC progression. Notably, unlike a previous DDA-MS study of species-
specific proteomic analysis in subcutaneous breast cancer xenografts (Wang et al., 2017), our 
study was undertaken in an orthotopic intraductal model which better recapitulates the 
mammary gland microenvironment. Our analysis reveal complex network alterations in both 
compartments, and while the human tumour cells show an expected upregulation of migration 
pathways during progression to invasive disease, we make the unanticipated discovery that 
the mouse stroma also undergoes extensive remodelling with an enrichment of cell migration 
and motility networks upon DCIS progression. In the mouse dataset, the highest observed 
increase in migration-associated protein expression levels between early (4w & 6w) versus 
late (10w) timepoints were in the S100a8 and S100a9 proteins (Table S4). These two proteins 
together form the calprotectin complex and stromal cells secreting calprotectin have been 
previously observed in the microenvironment of pancreatic cancer (Nedjadi et al., 2018). 
Additionally S100a8 has been reported to increase the migration and proliferation of colorectal 
and pancreatic cancer cells in vitro (Nedjadi et al., 2018) and has also been associated with 
metastasis formation in breast cancer (Zhong et al., 2018). MIF was found to be exclusively 
upregulated in the human DCIS.com cells at 10 week post-injection but not in the mouse 
stromal cells (Table S3) Increased levels of MIF has been reported in many cancer types 
including pancreatic cancer (Tan et al., 2014), hepatocellular cancer (Huang et al., 2014) or 
head and neck cancer (Kindt et al., 2013). Experiments with the murine breast cancer cell line 
4T1 have shown that overexpression of MIF promotes tumour metastasis (Simpson et al., 
2012) and protects cancer cells from immunogenic cell death (Balogh et al., 2018). Finally, we 
determine that LGALS3, CD44, FN1 and EZR were upregulated in both tumour and host 
stromal datasets. These proteins have been extensively shown in published literature to 
regulate cytoskeleton remodelling, epithelial-mesenchymal transition and increased cell 
motility (Pucci-Minafra et al., 2017, Mani et al., 2008, Bruce et al., 2007), all of which are 
important in breast cancer progression to invasive disease. These examples highlight the 
utility of this deconvolution pipeline in dissecting the individual roles of the tumour cells and 
the associated stroma in cancer biology. This dataset serves as a rich resource of tumour and 
microenvironmental proteins for future functional investigation, candidate biomarkers for 
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stratifying DCIS patients with increased risk of progressing to IBC, as well as targets for drug 
discovery for delaying DCIS progression. 
 
There are several limitations to the XenoSWATH pipeline. Because the method focuses on 
quantifying peptides that are both proteotypic and species-discriminating, a significant number 
of proteins with high sequence similarity between mouse and human are filtered out and lost 
during the process, resulting in the quantification of a reduced subset of the proteome. Despite 
this limitation, we are still able to readily identify key pathways that are operating in both the 
human and mouse compartment. Given that the stroma is composed of a number of different 
cell types including fibroblasts, endothelial cells and immune cells; as with other population-
level based measurement methodologies, the XenoSWATH pipeline is unable to resolve the 
individual contribution of specific stromal cell types to the aggregate proteomic data. Extending 
in silico transcriptomic deconvolution strategies that are currently being used to estimate 
stromal cell types to proteomic data may provide better resolution and address this 
shortcoming in future (Sturm et al., 2019).  
 
Collectively, our study has generated the MouseRefSWATH comprehensive mouse reference 
spectral library as a standardised community resource for use in future mouse SWATH-MS 
studies, which will not only remove the need for the generation of study-specific libraries but 
will also improve inter-laboratory reproducibility. We further present a new XenoSWATH 
analysis pipeline for species-specific deconvolution of xenograft proteomic data which opens 
new possibilities for the in-depth and reproducible assessment of tumour-host interactions in 
murine xenograft models. Moving forward, we anticipate that these tools will have broad 
applications in addressing key biological research questions involving this widely used model 
organism.  
 
Methods 
Murine organs, primary cells and cell lines 
Isolation of T-cells was carried out under Swiss animal experiment regulations. All other animal 
work was carried out under UK Home Office project and personal licenses following local 
ethical approval from the Institutional Animal Ethics Committee Review Board and in 
accordance with local and national guidelines. Mammary gland (n=2), liver (n=1) and lung 
(n=2) organs were dissected from two 14-week-old to 18-week-old virgin female SCID Beige 
mice. Brain (n=2), heart (n=2) and kidney (n=1) organs were dissected from two 6 months old 
female NCR nude mice. Axillary lymph nodes (n=6) and bronchial lymph nodes (n=6) were 
dissected from three 2-4 months old C57BL/6N male and female mice. All tissue specimens 
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were briefly washed in cold phosphate-buffered saline (PBS) to remove excess blood and 
immediately snap frozen in liquid nitrogen and stored at -80 ºC. 
  
Primary CD8+ effector T-cells were isolated from splenocytes of OT-I mice and cultured in 
Roswell Park Memorial Institute (RPMI) medium with 10% foetal bovine serum (FBS) (Gibco), 
1% penicillin-streptomycin and 0.1% β-mercaptoethanol. In order to activate OT-I CD8+ T-
cells, OT-I splenocytes were treated with 1 μg/ml OVA257-264 peptides in the presence of 10 
ng/ml IL-2 for 3 days while the non-stimulated resting CD8+ T-cells were collected after 
culturing with IL-2 alone. Immortalized normal (NF1) and cancer-associated fibroblasts (CAF1) 
(Calvo et al., 2013) were cultured in Dulbecco’s Modified Eagle Medium (DMEM) 
supplemented with 10% FBS, 1x GlutaMAX (Gibco), 0.5% penicillin-streptomycin and 1x 
insulin-transferrin-selenium A (ITS-A) (Gibco). NIH-3T3 cells were cultured in DMEM 
supplemented with 10% FBS/100units/ml penicillin/100mg/ml streptomycin. C2C12 and 4T1 
cells were cultured in RPMI supplemented with 10% FBS/100units/ml penicillin/100mg/ml 
streptomycin. Ba/F3 cells were cultured in the same media as 4T1 cells with the addition of 
5ng/ml IL-3. All cells were cultured in 95% air/5% CO2 atmosphere at 37°C. All cell lines were 
obtained from ATCC and evaluated for mycoplasma contamination prior to being used for 
experiments. 
 
Tissue and cell sample processing 
Tissue samples were cut into small pieces and placed into precooled tubes. All organs were 
processed as individual biological replicates with the exception of lymph nodes where 6 lymph 
nodes of the same type were pooled to generate sufficient material for MS analysis. High salt 
homogenization buffer consisting of 50mM Tris-HCl (pH 7.4), 0.25% 3-[(3-
Cholamidopropyl)dimethylammonio]-1-propanesulfonate hydrate (CHAPS, Sigma), 25mM 
EDTA, 3M NaCl (Sigma) and 10 KIU/ml aprotinin was added at 4 ml/g of tissue and samples 
were homogenized by 2 x 30 s pulses on ice with a LabGEN125 (Cole-Parmer) homogenizer. 
Homogenized samples were rotated for 20 min at 4 ºC. Proteins in homogenate were acetone 
precipitated by mixing with 4 volumes of ice cold acetone, vortexed and incubated 2 h at -
20 ºC. Samples were spun for 15 min at 15,000 rpm, 4 ºC, supernatant removed and resulting 
pellet was resuspended in 0.3 ml of urea buffer consisting of 8M urea (Sigma), 100 mM 
ammonium bicarbonate (Sigma). Protein concentration in samples was measured using the 
Pierce 660nm Protein assay (Thermo Scientific) as per manufacturer’s instructions and stored 
at -80 ºC until further processing. 
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Cells were harvested and lysed in 8 M urea buffer and protein concentration was measured 
by Pierce BCA assay (Thermo Scientific) as per manufacturer’s instructions. Cell lysates were 
stored at -80 ºC until further processing 
 
For each sample lysate, 200 µg of total protein was reduced with 20mM dithiothreitol (Sigma) 
at 56 ºC for 40 min and alkylated by 30mM iodoacetamide (Sigma) at room temperature for 
25 min in the dark. Samples were diluted to a final concentration of 2M urea, 100mM 
ammonium bicarbonate and digested at 37 ºC overnight with 4 µg of sequencing grade trypsin 
(Promega). Digestion was stopped by acidification to pH<4 with trifluoracetic acid (Sigma) and 
resulting peptides were desalted on SepPak C18light (Waters) cartridges as per 
manufacturer’s instructions. Desalted peptides were dried in a SpeedVac concentrator and 
stored at -20 ºC until fractionation. 
 
Fractionation by strong cation exchange (SCX) chromatography 
Dried peptides were resuspended in 100 µl of buffer SCX-A consisting of 10mM NH4COOH 
(Sigma) in 20% acetonitrile (Thermo Fisher), pH 2.7, vortexed, sonicated for 5 min and spun 
at 15,000 rpm for 1 min. The supernatant was loaded on a 2.1 x 100 mm Polysulfoethyl A 
column with 5 µm, 200 Å particles (PolyLC Inc.) and eluted with buffer SCX-B (500mM 
NH4COOH in 20% acetonitrile, pH 2.7) using a gradient of 0-10% of B in 2.5 min, 10-50% of 
B in 20 min, 50-100% of B in 7.5 min and 100% of B for 10 min. Twelve fractions were manually 
collected over 39 min with fraction 1 collected from 0 to 12 min and fraction 12 from 32 to 39 
min. The remaining 10 fractions were collected at 2 min intervals between 12 to 32 min. All 
SCX fractions were dried in a SpeedVac concentrator. 
 
Fractionation by high pH reverse phase (HpH RP) chromatography 
Dried peptides were resuspended in 100 µl of buffer HpH-A (0.1% NH4OH), vortexed, 
sonicated for 5 min and spun at 15,000 rpm for 1 min. The supernatant was loaded on a 2.1 
x 150 mm XBridge BEH C18 column with 5 µm, 130 Å particles (Waters) and eluted with buffer 
HpH-B (0.1% NH4OH in acetonitrile) using a linear gradient of 0-50% B over 60 min. Fractions 
were automatically collected between 5 and 50 min every 30 s into 96 well plate and fractions 
were pooled into 12 fraction (columns pooled) for 3T3 cells or 8 fractions (rows pooled) for 
4T1, BaF3 and C2C12 cells. Pooled fractions were dried in a SpeedVac concentrator. 
 
DDA MS data acquisition 
All fractions were resuspended in 20 µl of buffer A (2% acetonitrile, 0.1% formic acid) and 
peptide concentration was measured using the 280 nm NanoDrop assay. 1 µg of total peptide 
was analysed in DDA mode on an Agilent 1260 HPLC coupled to a TripleTOF 5600+ mass 
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spectrometer equipped with NanoSource III. Each fraction was spiked with 0.1 µl of iRT 
calibration mix (Biognosys, AG) and loaded onto a 0.3 x 5 mm ZORBAX C18 (Agilent 
Technologies) trap column. Peptides were separated on a 75 µm x 15 cm analytical column 
packed with Reprosil Pur C18AQ beads, 3 µm, 120 Å (Dr. Maisch, GmbH) with a manually 
pulled integrated spraying tip. A linear gradient of 2-40% of buffer B (98% acetonitrile, 0.1% 
formic acid) in 90 min and flow rate of 250 nl/min was used for peptide separation. All data 
were measured in positive mode. Full profile MS scans were acquired in the m/z mass range 
of 340-1500 with 250 ms filling time, MS/MS scans for the 20 most intense ions with charge 
state from 2+ to 5+ were acquired in m/z mass range of 280-1500 with 100ms filling time. 
Dynamic exclusion of fragmented ions was set to 12 s. 
 
DDA MS data processing and MouseRefSWATH reference spectral library generation 
All acquired DDA datasets were searched by SpectroMine (ver 1.0.21621.7 Sapphire) 
software (Biognosys AG) against a Swissprot mouse database (downloaded on 26/10/2018) 
with added iRT peptide sequences. Carbamidomethylation of cysteines was set as a fixed 
modification, oxidation of methionine and proline, deamidation of glutamine and asparagine, 
acetylation of protein N-terminus were set as variable modifications. A maximum of 2 missed 
cleavage sites were allowed during the search. False discovery threshold on peptide and 
protein level was set to 1% to filter search results. 
 
To generate final reference spectral library, retention times in each run were individually 
calibrated using iRT calibration peptides. Runs with low result of calibration fit (R2<0.8) were 
removed. To avoid inflation of FDR during the library generation from multiple datasets, 
Search Archives of all datasets were combined in SpectroMine and the MouseRefSWATH 
reference spectral library was built using following the parameters: minimum 3 and maximum 
6 transitions for each precursor, library-wide protein and peptide FDR threshold of 1%. The 
MouseRefSWATH library is deposited in ProteomeXchange with identifier PXD017209. 
 
Comparative analysis of publically available SWATH-MS data 
Publicly available datasets (PXD006382, PXD005044) were downloaded from data repository 
via the ProteomeCentral portal (Vizcaino et al., 2014) and analysed by Spectronaut (version 
13.6.190905) software (Biognosys AG). Either the MouseRefSWATH library or the relevant 
study-specific spectral library was uploaded into Spectronaut and all samples were processed 
using FDR threshold of 1% on peptide and protein levels. Mitochondrial proteins were 
identified by matching the list of quantified proteins with the MitoCarta 2.0 database (Calvo et 
al., 2016). It should be noted in the original published studies, older versions of the 
Spectronaut software with different settings were used by the authors which leads to the 
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discrepancies in number of reported quantified proteins in our study when compared to the 
original published data. Detailed Spectronaut settings for this study are shown in 
Supplemental Table S6. 
 
Mouse intraductal DCIS (MIND) model 
The MIND model was utilised in our studies as previously described (Behbod et al., 2009, 
Oliemuller et al., 2017). Briefly, a suspension of 5 × 104 MCF10DCIS.com-Luc cells was 
injected intraductally into mammary gland ducts of 6-10 week-old SCID-beige female mouse 
(n=7-8). Luminescence of the lesions was measured by in-vivo imaging assay (IVIS) on IVIS 
Illumina II (Perkin Elmer) to monitor tumour growth. Whole mammary glands with tumour were 
collected after 4, 6 or 10 weeks post injection, washed in cold PBS and freshly frozen. For 
each condition, 4 biological replicates were further processed and analysed by SWATH-MS. 
Haematoxylin and eosin (H&E) staining was performed on formalin-fixed and paraffin 
embedded samples and tissue images were scanned on Nanozoomer XR (Hamamatsu 
Photonics) automated slide scanner.  
 
MIND model sample processing and SWATH-MS data acquisition 
Whole mammary glands with tumours (n=4 for each time point) were homogenized in high salt 
homogenization buffer, proteins were precipitated with ice-cold acetone at -20 ºC, centrifuged 
and the resulting pellet was resuspended in 0.3 ml of urea buffer. 20µg of total protein was 
digested in solution by trypsin as described above, desalted on OMIX tips as per 
manufacturer’s instructions and dried in a SpeedVac concentrator. Dried samples were 
resuspended in 20µl of buffer A and analysed in SWATH-MS mode on an Agilent HPLC 
coupled to TripleTOF 5600+ mass spectrometer and operated by Analyst 1.5 software 
(SCIEX). 1 µg of sample was spiked with 0.1 µl of iRT peptides and loaded onto a 0.3 x 5 mm 
ZORBAX C18 (Agilent Technologies) trap column. Peptides were separated on a 75 µm x 15 
cm analytical column packed with Reprosil Pur C18AQ beads, 3 µm, 120 Å (Dr. Maisch, 
GmbH) with a manually pulled integrated spraying tip. A linear gradient of 2-40% of buffer B 
in 120 min and flow rate of 250 nl/min was used for peptide separation. All data were acquired 
in positive ion mode in SWATH mode using cycles comprising of one 100ms profile MS scan 
over the m/z mass range of 340-1500, followed by 60 SWATH fragmentation windows with a 
fixed width of 12 Da over the m/z range of 380-1100 and filling time of 50 ms. All SWATH-MS 
data were acquired in technical duplicates. The SWATH-MS data is deposited in 
ProteomeXchange with identifier PXD017209. 
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Implementing XenoSWATH species specific deconvolution pipeline and MIND model 
SWATH-MS data processing 
A combined FASTA file was generated in NotePad text editor (Microsoft) from individual 
FASTA files containing human (20,316 protein sequences), mouse (16,997 protein 
sequences) and iRT peptides.The human and mouse FASTA files were downloaded from 
SwissProt (downloaded on 26/10/2018) and the FASTA file with iRT sequences was 
downloaded from Biognosys website (https://www.biognosys.com/shop/irt-
kit#SupportMaterials). All entries from the mouse and iRT FASTA files were copied and 
inserted into the human FASTA file which was then saved as a new combined FASTA file. 
The acquired MIND model SWATH-MS data were processed in Spectronaut using the 
MouseRefSWATH reference spectral library, the published pan-Human reference spectral 
library (Rosenberger et al., 2014) and the combined FASTA file. The SWATH-MS data was 
first searched using the MouseRefSWATH library. Using the combined FASTA file and 
MouseRefSWATH library, Spectronaut selects only the mouse species discriminating 
proteotypic peptides from the MouseRefSWATH library for the quantification of murine 
proteins. The same approach was repeated with pan-Human library for the quantification of 
human species discriminating proteotypic peptides. All searches were performed with 1% FDR 
threshold on peptide and protein level (detailed Spectronaut settings are shown in 
Supplementary methods). In this manner, two separate proteomic datasets were obtained, 
one for the tumour component (human) and the other for the host stromal compartment 
(mouse). The datasets were separately quantile normalized using proBatch package (Cuklina 
et al., 2018) in R (www.r-project.org) and statistically analysed by Student’s two-tailed t-test 
with multiple testing correction (Benjamini and Hochberg, 1995) in Perseus (version 1.5.6.0, 
https://maxquant.net/perseus/) (Tyanova et al., 2016). Results were considered statistically 
significant when FDR-adjusted p-value < 0.05. Analysis of ontologies enriched in 10w versus 
4w & 6w was performed using GSEA desktop application (https://www.gsea-
msigdb.org/gsea/index.jsp) against human or mouse MSigDb of biological processes 
(Subramanian et al., 2005, Mootha et al., 2003). FDR threshold for multiple testing correction 
was set to 0.1 using genotype permutations due to low number of biological replicates. Protein 
networks were visualized in Cytoscape (version 3.7.1, www.cytoscape.org) (Shannon et al., 
2003) and clustered by the MCL clustering algorithm in clusterMaker2 Cytoscape 
plugin(Morris et al., 2011). For the generation of protein networks in Cytoscape, a fold change 
cut-off of at least Log2 0.58 was applied.  
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Table 1: Overview of the samples used for mouse reference spectra library generation 
 
Sample 
Sample 
type 
Mouse/cell 
strain 
Detailed sample description 
Liver tissue 
SCID-beige 
mice 
dissected from 14-18 week old female 
mouse 
Lung tissue 
SCID-beige 
mice 
dissected from 14-18 week old female 
mouse 
Mammary gland tissue 
SCID-beige 
mice 
dissected from 14-18 week old female 
mouse 
Brain tissue 
NCR nude 
mice 
dissected from 6 months old female 
mouse 
Kidney tissue 
NCR nude 
mice 
dissected from 6 months old female 
mouse 
Heart tissue 
NCR nude 
mice 
dissected from 6 months old female 
mouse 
Axillary lymph 
nodes 
tissue 
C57BL/6N 
mice 
dissected from 2-4 months old mouse, 
males and females  
Bronchial lymph 
nodes 
tissue 
C57BL/6N 
mice 
dissected from 2-4 months old mouse, 
males and females  
NIH/3T3 cell line ATCC CCL 92 mouse embryonic fibroblast 
4T1 cell line 
ATCC CRL 
2539 
mouse epithelial cell, mammary gland 
tumour origin 
Ba/F3 cell line ATCC 300 mouse IL-3 dependent pro-B cell line 
C2C12 cell line 
ATCC CRL 
1772 
mouse C3H muscle myoblast 
Cancer 
associated 
fibroblast (CAF1) 
cell line CAF1 
immortalized fibroblast isolated from 
mammary carcinoma tissue of FVB/n 
mouse 
Normal fibroblast 
(NF1) 
cell line NF1 
immortalized fibroblast isolated from 
normal mammary glands of FVB/n 
mouse 
Normal T-cells 
primary 
cells 
OT-I 
Primary CD8+ effector T cells isolated 
from splenocytes of OT-I mouse 
Activated T-cells 
primary 
cells 
OT-I 
Primary CD8+ effector T cells isolated 
from splenocytes of OT-I mouse and 
stimulated by ovalbumin peptides 
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Table 2: Overview of the DDA datasets used for the generation of the MouseRefSWATH 
reference spectral library.  
Sample Sample type Fractionation 
Number 
of runs 
Total 
number of 
protein IDs 
Liver tissue SCX 12 4471 
Lung tissue SCX 24 6295 
Brain tissue SCX 24 6366 
Kidney tissue SCX 12 5093 
Heart tissue SCX 24 3284 
Axillary lymph node tissue SCX 12 5643 
Bronchial lymph node tissue SCX 12 6358 
Mammary gland tissue SCX 24 5433 
3T3 cell line SCX, HpH-RP 24 5799 
4T1 cell line SCX, HpH-RP 20 6293 
Ba/F3 cell line HpH-RP 8 5353 
C2C12 cell line SCX, HpH-RP 20 6681 
CAF1 cell line SCX 12 5390 
NF1 cell line SCX 12 3702 
Normal T-cells primary cells SCX 12 6060 
Activated T-cells primary cells SCX 12 6018 
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Figures 
 
 
 
Figure 1. Overview of the sample types and schematic workflow used to build the 
MouseRefSWATH reference spectral library. 15 unique sample types comprising 7 mouse 
organs, 2 primary cell types and 6 mouse cell lines were analysed to maximise proteome 
coverage. The workflow is comprised of a first step of sample preparation and data acquisition 
of each sample by DDA-based LC-MS/MS. In the second step, the resulting proteomic data 
was subjected to processing and spectral library generation using the combined Search 
Archives approach in the SpectroMine software. The subsequent evaluation of the 
performance of the MouseRefSWATH library was undertaken with the Spectronaut software 
utilising two publicly available datasets. 
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Figure 2. Characteristics and performance of the MouseRefSWATH reference spectral 
library. A) Detailed characteristics of the generated MouseRefSWATH library. B) Percentage 
proteome coverage of MouseRefSWATH library in comparison with published spectral 
libraries for other eukaryotic organisms, including human [15], zebrafish [17] and yeast [18].  
C) Peptide coverage of the individual proteins in the MouseRefSWATH library. 90.6% of the 
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proteins are represented by more than one unique peptide. D) Contribution plot of the tissue- 
or cell-specific proteins to the overall composition of the MouseRefSWATH library. The bar 
chart at the top of the figure depicts the total number of proteins identified in the overlap of 
datasets contributed by different organs/cell types as indicated in the dot plot below. The bar 
chart on the left indicates total number of proteins identified in the individual datasets from 
each organ or cell type. E) Venn diagram depicting overlap of mitochondrial proteins detected 
by the MouseRefSWATH library and study-specific library based on analysis of the 
PXD005044 dataset (Williams et al., 2018). F) Similarity matrix showing Pearson’s correlation 
coefficient of the 640 overlapping mitochondrial proteins which were quantified by either the 
MouseRefSWATH library or the study-specific library. 5-8 animals were used for each tissue 
site. BAT is brown adipocyte tissue and quad is quadriceps. G) Venn diagram depicting 
overlap of hippocampal proteins detected by the MouseRefSWATH library and study-specific 
library based on analysis of the PXD006382 dataset (von Ziegler et al., 2018). H) Similarity 
matrix showing Pearson’s correlation coefficient of the 943 overlapping hippocampal proteins 
which were quantified by either the MouseRefSWATH library or the study-specific library. Two 
hippocampal areas (CA1 and CA3) from 6 animals (a-f) were used.  
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Figure 3. XenoSWATH workflow of the species-specific deconvolution analysis 
pipeline. The ‘bulk tumour xenograft’ acquired SWATH-MS data is first subjected to two 
separate searches by either the MouseRefSWATH or the pan-Human library in the 
Spectronaut software to identify protein-specific (proteotypic) peptides. A combined FASTA 
file of human and mouse in silico digested peptides is then generated to enable subsequent 
peptide quantification of species-discriminating proteotypic peptides. For peptide 
quantification, Spectronaut will compare the sequences of the identified peptides from either 
the MouseRefSWATH or pan-Human library searches with the peptides sequences in the 
combined FASTA file. Because protein-specific (proteotypic) peptides that are not species-
discriminating (blue) occur more than once in the combined FASTA file, Spectronaut filters 
these peptides out. Only peptides which are both protein-specific and species-discriminating 
(purple for mouse and green for human) in the combined FASTA file are retained and 
subjected to quantification. The output of this pipeline is two quantified datasets, one specific 
for mouse proteins and the other for human proteins.  
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Figure 4. Quantitative proteomic profiling of DCIS progression to IBC in the mouse 
intraductal (MIND) xenograft model. A) Experimental workflow of SWATH-MS analysis of 
tumour xenografts.  MCF10DCIS.com-Luc cells were injected orthotopically into mouse 
mammary gland ducts through the nipple. Whole mammary glands with tumours were 
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removed at 4, 6 and 10 weeks (w) post-injection and subjected to sample preparation prior to 
SWATH-MS data acquisition and analysis by the XenoSWATH pipeline. B) Representative 
bioluminescence images as measured by IVIS at 4, 6 and 10w post-injection. C) Total 
bioluminescence flux reflecting tumour size in MIND model at 4, 6 and 10w post-injection (n=7 
for 4w and 6w samples, n=8 for 10w samples). p-value represents statistical significance of 
the difference between the sample groups calculated by two-tailed Mann-Whitney test. Each 
dot represents one biological replicate, error bars indicate mean and standard error of means. 
D) H&E images showing initial DCIS lesion formation in the MIND model at 4w which 
progresses to form an invasive tumour at 10w post-injection. Tumour microinvasion in lesion 
10w post-injection is indicated by arrowheads. E) Venn diagram showing the overlap of 
enriched ontologies for proteins that are significantly upregulated in the 10w specimens (n=4) 
versus the 4w (n=4) and 6w (n=4) specimens as identified by GSEA with FDR-adjusted p-
value <0.1. Ontologies associated with cell motility, migration and cytoskeleton organization 
are highlighted in red. F) Network depicting ontologies enriched in human (purple) and mouse 
(green) datasets (10w versus 4w and 6w) and their overlap as identified by GSEA. Detailed 
protein networks for two selected ontologies (cell motility and locomotion) are shown. In these 
networks, the protein node border colour represents the mouse dataset while the protein node 
fill colour represents the human dataset. Only proteins with expression Log2 fold change > 
0.58 in either the mouse or human dataset are displayed. Proteins that are not detected are 
represented by grey. 
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Table S1: Full proteomic dataset of human proteins obtained from MIND model 
experiment as processed by XenoSWATH species-specific deconvolution pipeline. 
Confidence of the protein identification is reported as FDR-adjusted p-value. 
Click here to Download Table S1 
Table S2: Full proteomic dataset of mouse proteins obtained from MIND model 
experiment as processed by XenoSWATH species-specific deconvolution pipeline. 
Confidence of the protein identification is reported as FDR-adjusted p-value. 
Click here to Download Table S2 
Table S3: List of human proteins with significantly altered expression in 10w samples 
compared to 4w & 6w samples. Log2 fold change (Log2FC) for each protein is reported 
along with the FDR-adjusted p-value from the two-tailed Student's t-test. 
Click here to Download Table S3 
Table S4: List of mouse proteins with significantly altered expression in 10w samples 
compared to 4w & 6w samples. Log2 fold change (Log2FC) for each protein is reported 
along with the FDR-adjusted p-value from the two-tailed Student's  t-test. 
Click here to Download Table S4 
Table S5: Overlapping ontologies enriched in both human and mouse dataset (Figure 
4E). GSEA normalized enrichment scores (NES) and FDR-adjusted p-values are shown 
based on analysis of 10w versus 4w & 6w samples. 
Click here to Download Table S5 
Table S6: Detailed Spectronaut settings used for XenoSWATH analysis 
Click here to Download Table S6 
Disease Models & Mechanisms: doi:10.1242/dmm.044586: Supplementary information
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